Company Filing History:
Years Active: 2000-2004
Title: Tracy Staton Angelly: Innovator in Genetic Research
Introduction
Tracy Staton Angelly is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of genetic research, particularly in relation to the BRCA1 gene, which is crucial for understanding breast and ovarian cancer susceptibility. With a total of 2 patents, Angelly's work has the potential to impact cancer diagnostics and treatment.
Latest Patents
Angelly's latest patents include groundbreaking inventions related to the BRCA1 gene. The first patent, titled "Coding sequence haplotype of the human BRCA1 gene," focuses on isolated coding sequences and the protein sequences they encode. This invention provides the coding sequence for the BRCA1(omi4) gene, which is instrumental in identifying individuals with an increased genetic susceptibility to breast or ovarian cancer due to inherited mutations. Additionally, this patent outlines methods for gene therapy and protein replacement therapy using the BRCA1(omi4) coding sequence and protein.
The second patent, "Cancer susceptibility mutations of BRCA1," identifies new mutations within the BRCA1 gene. These mutations are located at specific nucleotide numbers and are crucial for the accurate detection of mutations in test samples. The patent describes a process for identifying sequence variations in BRCA1 polynucleotide sequences, utilizing allele-specific sequence-based assays for efficient and precise mutation detection.
Career Highlights
Throughout his career, Angelly has worked with various companies that focus on genetic research and biotechnology. Notable among these are Oncormed, Inc. and Gene Logic, Inc. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative work on the BRCA1 gene.
Collaborations
Angelly has collaborated with several professionals in the field, including Sheri J Olson and Tammy Lawrence. These collaborations have likely enriched his research and contributed to the development of his patents.
Conclusion
Tracy Staton Angelly is a prominent inventor whose work on the BRCA1 gene has the potential to revolutionize cancer diagnostics and treatment. His patents reflect a deep understanding of genetic research and a commitment to improving patient outcomes.